An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Amneal to Participate at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) will participate in investor conferences, including Jefferies 14th Annual Global Healthcare Conference on November 14, 2023, in London, UK, and Piper Sandler 35th Annual Healthcare Conference on November 28, 2023, in New York, New York. The presentations will be available via live webcast on the company's Investor Relations section of the website, with a replay available for 90 days after the event.
Positive
None.
Negative
None.
BRIDGEWATER, N.J.--(BUSINESS WIRE)--
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the below investor conferences.
Jefferies 14th Annual Global Healthcare Conference
November 14, 2023
London, UK Presentation – 8:30 AM GMT
Piper Sandler 35th Annual Healthcare Conference
November 28, 2023
New York, New York Presentation – 9:00 AM EST
A live webcast of the presentations will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com. A replay of the webcast will be posted shortly after the presentation and will be available for 90 days following the event.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully integrated global pharmaceuticals company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com.
Which investor conferences will Amneal Pharmaceuticals participate in?
Amneal Pharmaceuticals will participate in Jefferies 14th Annual Global Healthcare Conference on November 14, 2023, in London, UK, and Piper Sandler 35th Annual Healthcare Conference on November 28, 2023, in New York, New York.
Where can I access the presentations?
The presentations will be accessible through the Investor Relations section of Amneal Pharmaceuticals' website at https://investors.amneal.com.
Will there be a replay of the webcast?
Yes, a replay of the webcast will be posted shortly after the presentation and will be available for 90 days following the event.